Using data from over 3400 colorectal cancer patients, the researchers found that H/L EOCRC patients had higher rates of specific MAPK pathway alterations compared to NHW patients, while no major differences were observed in the JAK/STAT pathway. The gene discussed is SOAT1; the disease is colorectal cancer.